The Inhibitory Effect of Gallamine on Muscarinic Receptors

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1976 Nov 1

PMID 990587

Citations 60

Authors

A L Clark

F Mitchelson

Affiliations

Soon will be listed here.

Abstract

1 The inhibitory effect of gallamine (1.1 muM-1.1 mM) on negative inotropic responses to acetylcholine (ACh) or carbachol (CCh) was investigated in isolated electrically stimulated atria of the guinea-pig. Gallamine caused parallel rightward shifts of the dose-response curves to the agonists, with no depression of the maximal response. 2 Gallamine (0.11 - 1.1 mM) produced a greater degree of antagnism towards CCh than towards ACh. With either agonist, the degree of antagonism produced by gallamine in high concentrations was less than that expected for a competitive antagonist.. 3 Similar findings were made when either negative inotropic or chronotropic responses were recorded in spontaneously beating guinea-pig atria. The inhibitory effect of gallamine against the negative inotropic response to cholinomimetics in electrically stimulated atria was not altered either in the presence of propranol (17 muM) or in atria obtained from guinea-pigs pretreated with diisopropylphosphorofluoridate (DEP) 12.5 mumol/kg, in divided doses over 3 days). 4 When ACh was used as the agonist, combination of gallamine with atropine (0.05-0.4 muM) produced dose-ratios which were less than expected for combination of two competitive antagonists. The same phenomenon was observed in atria obtained from guinea-pigs pretreated with DFP. 5 It is suggested that the antagonism produced by gallamine is a type of non-competitive inhibition, which has been termed "metaffinoid antagonism". An antagonist of this type allosterically alters the affinity of the agonist for its binding site, rather than changing the effectiveness of the agonist-receptor interaction.

Citing Articles

Allosteric Modulation of Muscarinic Receptors by Cholesterol, Neurosteroids and Neuroactive Steroids.

Szczurowska E, Szanti-Pinter E, Randakova A, Jakubik J, Kudova E Int J Mol Sci. 2022; 23(21).

PMID: 36361865 PMC: 9656441. DOI: 10.3390/ijms232113075.

Multitargeting nature of muscarinic orthosteric agonists and antagonists.

Myslivecek J Front Physiol. 2022; 13:974160.

PMID: 36148314 PMC: 9486310. DOI: 10.3389/fphys.2022.974160.

Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders.

Johnson C, Kangas B, Jutkiewicz E, Bergman J, Coop A Biomedicines. 2022; 10(2).

PMID: 35203607 PMC: 8962391. DOI: 10.3390/biomedicines10020398.

Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias.

van der Westhuizen E, Choy K, Valant C, McKenzie-Nickson S, Bradley S, Tobin A Front Pharmacol. 2021; 11:606656.

PMID: 33584282 PMC: 7878563. DOI: 10.3389/fphar.2020.606656.

Current Advances in Allosteric Modulation of Muscarinic Receptors.

Jakubik J, El-Fakahany E Biomolecules. 2020; 10(2).

PMID: 32085536 PMC: 7072599. DOI: 10.3390/biom10020325.

References

Madden J, Mitchelson F . The interaction of hemicholinium-3 (HC-3) with cholinomimetics and atropine. Eur J Pharmacol. 1975; 32(1):17-29. DOI: 10.1016/0014-2999(75)90318-0. View

Todrick A . The inhibition of cholinesterases by antagonists of acetylcholine and histamine. Br J Pharmacol Chemother. 1954; 9(1):76-83. PMC: 1509379. DOI: 10.1111/j.1476-5381.1954.tb00820.x. View

McEwen L . The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain. J Physiol. 1956; 131(3):678-89. PMC: 1363485. DOI: 10.1113/jphysiol.1956.sp005493. View

ARIENS E, SIMONIS A, van Rossum J . A theoretical basis of molecular pharmacology; II. Interactions of one or two compounds with two interdependent receptor systems. Arzneimittelforschung. 1956; 6(10):611-21. View

ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View

Koch-Weser J, BLINKS J . THE INFLUENCE OF THE INTERVAL BETWEEN BEATS ON MYOCARDIAL CONTRACTILITY. Pharmacol Rev. 1963; 15:601-52. View

Paton W, Rang H . THE UPTAKE OF ATROPINE AND RELATED DRUGS BY INTESTINAL SMOOTH MUSCLE OF THE GUINEA-PIG IN RELATION TO ACETYLCHOLINE RECEPTORS. Proc R Soc Lond B Biol Sci. 1965; 163:1-44. DOI: 10.1098/rspb.1965.0058. View

DOUGHTY A, WYLIE W . An assessment of flaxedil (Gallamine triethiodide, B.P.). Proc R Soc Med. 1951; 44(5):375-88. PMC: 2081706. View

RIKER Jr W, WESCOE W . The pharmacology of Flaxedil, with observations on certain analogs. Ann N Y Acad Sci. 1951; 54(3):373-94. DOI: 10.1111/j.1749-6632.1951.tb39932.x. View

10.

Offermeier J, van den Brink F . The antagonism between cholinomimetic agonists and beta-adrenoceptor stimulants. The differentiation between functional and metaffinoid antagonism. Eur J Pharmacol. 1974; 27(2):206-13. DOI: 10.1016/0014-2999(74)90147-2. View

11.

Loffelholz K . Autoinhibition of nicotinic release of noradrenaline from postganglionic sympathetic nerves. Naunyn Schmiedebergs Arch Pharmakol. 1970; 267(1):49-63. DOI: 10.1007/BF00997114. View

12.

Bieger D, LULLMANN H, Wassermann O . [On an acute anti-acetylcholine effect of hemicholinium no. 3 on the guinea pig atrium]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968; 259(5):386-93. View

13.

STEPHENSON R, GINSBORG B . Potentiation by an antagonist. Nature. 1969; 222(5195):790-1. DOI: 10.1038/222790a0. View

14.

Mitchelson F . Differentiation between the actions of acetylcholine and tetramethylammonium on the isolated taenia of the guinea-pig caecum by hemicholinium-3. Br J Pharmacol. 1971; 42(1):43-55. PMC: 1666985. DOI: 10.1111/j.1476-5381.1971.tb07085.x. View

15.

Gingsborg B, STEPHENSON R . On the simultaneous action of two competitive antagonists. Br J Pharmacol. 1974; 51(2):287-300. PMC: 1776755. DOI: 10.1111/j.1476-5381.1974.tb09659.x. View

16.

. Structure-activity relationship of mono- and bisquaternary pyridines in regard to their parasympatholytic effects. Toxicol Appl Pharmacol. 1972; 23(3):443-54. DOI: 10.1016/0041-008x(72)90046-4. View

17.

Roufogalis B, Quist E, Wickson V . Effect of ligands on a discontinuous temperature dependence of the decarbamylation reaction of erythrocyte acetylcholinesterase. Biochim Biophys Acta. 1973; 321(2):536-45. DOI: 10.1016/0005-2744(73)90196-4. View

18.

. A novel approach to the questions of allosteric properties or a 'receptor reserve' of drug binding sites of intestinal smooth muscle cells. FEBS Lett. 1974; 39(1):61-6. DOI: 10.1016/0014-5793(74)80017-7. View

19.

Clark A, Mitchelson F . The effect of 4-(1-naphthylvinyl)-pyridine (NVP), a choline acetylase inhibitor, on autonomically innervated tissues of the rat. Eur J Pharmacol. 1974; 27(1):34-9. DOI: 10.1016/0014-2999(74)90199-x. View

20.

Roufogalis B, Quist E . Relative binding sites of pharmacologically active ligands on bovine erythrocyte acetylcholinesterase. Mol Pharmacol. 1972; 8(1):41-9. View